Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-01-13 @ 7:53 AM
Study NCT ID:
NCT02493751
Status:
COMPLETED
Last Update Posted:
2022-02-18
First Post:
2015-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-26
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-07
First Submit QC Date:
None
Study First Post Date:
2015-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-27
Results First Submit QC Date:
None
Results First Post Date:
2019-06-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-06
Last Update Post Date:
2022-02-18
Last Update Post Date Type:
ACTUAL